Steven Edelman, MD- Program Chair

Professor of Medicine
University of California San Diego

Veterans Affairs Medical Center

San Diego, CA

Jeremy Pettus, MD

Assistant Professor of Medicine
University of California San Diego
San Diego, CA

Rayhan A. Lal, MD

Stanford University Medical Center

Sunnyvale, CA

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable. 

The following faculty reported relevant financial relationships during the content development process for this activity:  

• Steven Edelman, MD: Advisory Board Member, AstraZeneca, BrightSight, Ipsen, Lexicon Pharmaceuticals, Inc., Novo Nordisk, Inc., Senseonics; Speaker, Lilly USA, Inc., MannKind Corporation, Merck, Sanofi-Aventis
• Jeremy Pettus, MD: Consulting, Sanofi, Novo Nordisk, Inc., MannKind Corporation, Lexicon Pharmaceuticals, Inc.
• Rayhan A. Lal, MD: Consulting, Abbott Diabetes Care, Biolinq, Capillary Biomedical, Tidepool

The following Special Programs Committee member who planned and reviewed content for this activity reported relevant financial relationships:  

• Andjela T. Drincic, MD: Advisory Board Member, Corcept  

The following Special Programs Committee members reported financial relationships: 

• Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca  
• Steven T. Harris, MD: Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health  
• Angela M. Leung, MD: Speaker,Medical Education Resources, MCE Conferences 
• Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck  

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.  

The following Special Programs Committee members reported no relevant financial relationships: 

• Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD, Savitha Subramanian, MD;  Soleymani Taraneh, MD; Steven Weitzman, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.